Global Antidiabetics Market Report 2024 - A $313.9 Billion Market by 2034, with CAGR of 10.9% During 2024-2034
18. März 2024 05:10 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region" report has been added to ...
Global Diabetes Care Drugs Market to Reach $103 Billion by 2027: Asia-Pacific is Poised to Show a Considerable Growth Rate
06. März 2023 09:48 ET
|
Research and Markets
Dublin, March 06, 2023 (GLOBE NEWSWIRE) -- The "Global Diabetes Care Drugs Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The global diabetes care...
COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment
18. August 2022 09:00 ET
|
University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Published in the New England Journal of Medicine, researchers — led by the University of Minnesota Medical School and School of Public Health...
Investigation Report on China's Metformin Market 2021-2025
31. Dezember 2021 05:33 ET
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Metformin Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The analyst expects that with...
[UPDATED] CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
24. November 2021 15:05 ET
|
Curative Biotechnology, Inc.
Company’s First In-license Pipeline Product to Enter Pre-clinical Studies Boca Raton, FL, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the...
CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
24. November 2021 10:00 ET
|
Curative Biotechnology, Inc.
Company’s First In-license Pipeline Product to Enter Pre-clinical Studies Boca Raton, FL, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the...
Global Antidiabetic Drug Markets Report 2021: A-Glucosidase Inhibitors, Biguanides, DPP-IV Inhibitors, Meglitinides, Sulfonylureas, Thiazolidinediones - Forecast to 2026
25. August 2021 09:23 ET
|
Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of Covid-19 with...
University of Minnesota Medical School launches clinical trial studying metformin treatment for COVID-19
15. März 2021 09:54 ET
|
University of Minnesota Medical School
Minneapolis / St. Paul, March 15, 2021 (GLOBE NEWSWIRE) -- A new multi-site clinical trial led by the University of Minnesota Medical School is studying the effectiveness of metformin, a generic...
Type 2 Diabetes Trial Results Presented by Study Investigators at American Diabetes Association Annual Meeting
18. Juni 2014 23:19 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, June 18, 2014 (GLOBE NEWSWIRE) -- Results from the Phase 2 trial of Mesoblast's proprietary adult stem cells in type 2 diabetes patients have been presented by Jay...